David, living with Hereditary ATTR (hATTR) amyloidosis
This video was created for UK audiences. David, from the UK, is living with Hereditary ATTR (hATTR) amyloidosis - an inherited, progressive disease caused by a genetic mutation that results in the misfolding of transthyretin (TTR) proteins. He and his wife Sue discuss the moment of diagnosis. NP-IRL-00006
▶︎
John, living with Hereditary ATTR (hATTR) amyloidosis
▶︎
The Coyle Family Story - Living with Hereditary ATTR (hATTR) amyloidosis
▶︎
Alnylam & RNAi Therapeutics: Making our Medicines
▶︎
Alnylam Act - No Charge, Third Party Genetic Testing & Counseling
▶︎
Marc – Living with Wild-Type ATTR Amyloidosis with Cardiomyopathy
▶︎
Liana (Brazil) – Living with hATTR Amyloidosis
▶︎
Alnylam Challengers: Improving Access to Healthcare in Boston by Investing in Care Navigators
▶︎
Alnylam's siRELIS(TM) Enzymatic Ligation Platform
▶︎
One family’s journey with hereditary TTR amyloidosis: Dan and Diana
▶︎
Alnylam & RNAi Therapeutics: Making our Medicines
▶︎
Sophia's experience living with hATTR amyloidosis
▶︎
RNAi, a promising platform for drug development
▶︎
Chen (Brazil) – Living with hATTR Amyloidosis
▶︎
Alnylam & RNAi Therapeutics: Silencing Disease. Amplifying Life.
▶︎
Alnylam Announces $250 Million Expansion of U.S. RNAi Therapeutics Manufacturing Facility
▶︎